Neos Therapeutics Announces Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Neos Therapeutics (NEOS) Posts Wider-than-Expected Q2 Loss
September 3, 2015 7:07 AM EDTNeos Therapeutics (NASDAQ: NEOS) reported Q2 EPS of ($7.76), $3.45 worse than the analyst estimate of ($4.31). Revenue for the quarter came in at $1.48 million versus the consensus estimate of $1.7 million.
For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.
... More